Economics and public health: Engaged to be happily married!

European Journal of Public Health

Volumn 17, Issue 2, 2007, Pages 122-123

  Brouwer, Werner ^a,c   Exel, Job Van ^a   Baal, Pieter Van ^b   Polder, Johan ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DECISION MAKING; ECONOMICS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROMOTION; LIFESTYLE; OBESITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; RANDOMIZATION; SHORT SURVEY; SMOKING; SOCIAL WELFARE;

HEALTH EXPENDITURES; HEALTH TRANSITION; HUMANS; INCOME; LIFE EXPECTANCY; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION; SOCIOECONOMIC FACTORS;

EID: 34047208810     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckl074     Document Type: Short Survey

References (10)

1. Ronckers ET, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectiveness. Med Decis Making 2005;25:437-48.
2. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004;8:iii-iv, 1-182.
3. Ekstrand KR, Christiansen ME. Outcomes of a non-operative caries treatment programme for children and adolescents. Caries Res 2005;39:455-67.
4. Cutler DM, McClellan M. Is technological change in medicine worth it? Health Aff 2001;20:11-29.
5. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004;329:972-5.
6. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20:332-42.
7. Dranove D. What's your life worth? New York: FT Prentice Hall, 2003.
8. Brouwer WBF. Too important to ignore: informal caregivers and other significant others. Pharmacoeconomics 2006;24:39-41.
9. Van Roijen L, Koopmanschap MA, Rutten FF, van der Maas PJ. Indirect costs of disease; an international comparison. Health Policy 1995;33:15-29.
10. Chaloupka FJ, Warner KE. The economics of smoking. In: Culyer AJ, Newhouse J, editors. Handbook of health economics. Amsterdam: Elsevier Science, 2000;1539-1627.